Xanthones and Anthranoids from the Medicinal Plants of Africa

Medicinal Plant Research in Africa: Pharmacology and Chemistry

Volumn , Issue , 2013, Pages 393-434

  Mazimba, Ofentse ^a   Nana, Frederic ^b   Kuete, Victor ^c   Singh, Girija S ^a  

^a UNIVERSITY OF BOTSWANA   (Botswana)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF DSCHANG   (Cameroon)

Author keywords

Africa; Biosynthesis; Medicinal plants; Pharmacological activity; Xanthones

Indexed keywords

EID: 84896490714     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405927-6.00011-4     Document Type: Chapter

References (161)

1. El-Seedi H.R., El-Ghorab D.M.H., El-Barbary M.A., Zayed M.F., Goransson U., Larsson S., et al. Naturally occurring xanthones; latest investigations: isolation, structure elucidation and chemosystematic significance. Curr Med Chem 2009, 16:2581-2626.
2. Peres V., Nagem T.J., De oliveira F.F. Tetraoxygenated naturally occurring xanthones. Phytochemistry 2000, 55(7):683-710.
3. Viera L.M.M., Kijjoa A. Naturally occurring xanthone: recent development. Curr Med Chem 2005, 12(21):2413-2446.
4. Masters K.-S., Brase S. Xanthones from fungi, lichens, and bacteria: the natural products and their synthesis. Chem Rev 2012, 112(7):3717-3776.
5. Yang C.-H., Ma L., Wei Z.-P., Han F., Gao J. Advances in isolation and synthesis of xanthones derivatives. Chin Herb Med 2012, 4(2):87-102.
6. Jensen S.R., Schripsema J. Chemotaxonomy and pharmacology of Gentianaceae. Gentianaceae-systematics and natural history 2002, 573-631. Cambridge University Press, Cambridge. L. Struwe, V. Albert (Eds.).
7. Pinto M.M.M., Sousa M.E., Nancimento M.S.J. Xanthone derivatives: new insights in biological activities. Curr Med Chem 2005, 12(21):2517-2538.
8. Pouli N., Marakos P. Fusedxanthone derivatives as antiproliferative agents. Anticancer Agents Med Chem 2009, 9(1):77-98.
9. Wang L.L., Liu H.G., Zhang T.J. Advances in studies on xanthones. Chin Trad Herb Drugs 2010, 41(7):1196-1206.
10. El-Seedi H.R., El-Barbary M.A., El-Ghorab D.M., Bohlin L., Borg-Karlson A.K., Göransson U., et al. Recent insights into the biosynthesis and biological activities of natural xanthones. Curr Med Chem 2010, 17(9):854-901.
11. Li G.-L., He J.-Y., Zhang A., Wan Y., Wang B., Chen W.-H. Toward potent α-glucosidaes inhibitors based on xanthones: a closer look into the structure activity correlations. Eur J Med Chem 2011, 46(9):4050-4055.
12. Franklin G., Conceic L.F.R., Kombrink E., Dias A.C.P. Xanthones biosynthesis in Hypericum perforatum cells provides antioxidant and antimicrobial protection upon biotic stress. Phytochemistry 2009, 70(1):60-68.
13. Pontius A., Krick A., Kehraus S., Brun R., Konig G.M. Antiprotozoal activities of heterocyclic substituted xanthones from the marine derived fungus Chaetomium sp. J Nat Prod 2008, 71(9):1579-1584.
14. Alaribe C.S.A., Coker H.A.B., Shode F.O., Ayoola G., Adesegun S.A., Bamiro J., et al. Antiplasmodial and phytochemical investigations of leaf extracts of Anthocleista vogelii (Planch). J Nat Prod 2012, 5:60-67.
15. Lannang A.M., Komguem J., Ngninzeko F.N., Tangmouo J.G., Lontsi D., Ajaz A., et al. Bangangxanthone A and B, two xanthones from the stem bark of Garcinia polyantha Oliv. Phytochemistry 2005, 66(19):2351-2355.
16. Fouotsa H., Lannang A.M., Mbazoa C.D., Rasheed S., Marasini B.P., Ali M.Z., et al. Xanthones inhibitors of α-glucosidase and glycation from Garcinia nobilis. Phytochem Lett 2012, 5(2):236-239.
17. Ngouela S., Ndjakou B.L., Tchamo D.N., Zelefack F., Tsamo E., Connolly J.D. A prenylated xanthone with antimicrobial activity from the seeds of Symphonia globulifera. Nat Prod Res 2005, 19(1):23-27.
18. Meyer J.J.M., Rakuambo N.C., Hussein A.A. Novel xanthones from Securidaca longepedunculata with activity against erectile dysfunction. J Ethnopharmacol 2008, 119(3):599-603.
19. Nkengfack A.E., Azebaze G.A., Vardamides J.C., Fomum Z.T., van Heerden F.R. A prenylated xanthone from Allanblackia floribunda. Phytochemistry 2002, 60(4):381-384.
20. Azebaze A.G.B., Meyer M., Bodo B., Nkengfack A.E. Allanxanthone B, a polyisoprenylated xanthone from the stem bark of Allanblackia monticola Staner L.C. Phytochemistry 2004, 65(18):2561-2564.
21. Hostettmann K., Marston A., Ndjoko K., Wolfender J.-L. The potential of African plants as a source of drugs. Curr Org Chem 2000, 4(10):973-1010.
22. Viljoen A.M., Van Wyk B.E., Newton L.E. The occurrence and taxonomic distribution of the anthrones aloin, aloinoside and microdontin in Aloe. Biochem Syst Ecol 2001, 29(1):53-67.
23. Kouam S.F., Ngadjui B.T., Krohn K., Wafo P., Ajaz A., Choudhary M.I. Prenylated anthronoid antioxidants from the stem bark of Harungana madagascariensis. Phytochemistry 2005, 66(10):1174-1179.
24. Farah M.H., Andersson R., Samuelsson G. Microdontin A and B: two new aloin derivatives from Aloe microdonta. Planta Med 1992, 58(1):88-93.
25. Chen W., Van Wyk B.-E., Vermaak I., Viljoen A.M. Cape aloes-a review of the phytochemistry, pharmacology and commercialisation of Aloe ferox. Phytochem Lett 2012, 5(1):1-12.
26. Kimura Y., Sumiyoshi M., Taniguchi M., Baba K. Antitumor and antimetastatic actions of anthrone C-glucoside, cassialoin isolated from Cassia garrettiana heartwood in colon 26-bearing mice. Cancer Sci 2008, 99(11):2336-2348.
27. Yadav J.P., Arya V., Yadav S., Panghal M., Kumar S., Dhankhar S. Cassia occidentalis L.: a review on its ethnobotany, phytochemical and pharmacological profile. Fitoterapia 2010, 81(4):223-230.
28. Asamenew G., Bisrat D., Mazumder A., Aseres K. In vitro antimicrobial and antioxidant activities of anthrone and chromone from the latex of Aloe harlana Reynolds. Phytother Res 2011, 25(12):1756-1760.
29. Muller K., Gawlik I. Novel 10-substituted antipsoriaticanthrones as inhibitors of epidermal 12-lipoxygenase and lipid peroxidation in membranes. Biochem Pharmacol 1995, 50(12):2077-2083.
30. Beerhues L. Benzophenone synthase from cultured cells of Centaurium erythraea. FEBS Lett 1996, 383(3):264-266.
31. Raistrick H., Robinson R., White D. Studies in the biochemistry of micro-organisms: ravenelin (3-methyl-1:4:8-trihydroxyxanthone), a new metabolic product of Helminthosporium ravenelii Curtis and of H. turcicum Passerini. Biochem J 1936, 30(8):1303-1314.
32. Birch A.J., Baldas J., Hlubucek J.R., Simpson T.J., Westerman P.W. Biosynthesis of fungal xanthone ravenelin. J Chem Soc Perkin Trans I 1976, 898-904.
33. Austin M.B., Noel J.P. The chalcone synthase superfamily of type III polyketide synthases. Nat Prod Rep 2003, 20(1):79-110.
34. Abe I. Engineering of plant polyketide biosynthesis. Chem Pharm Bull 2008, 56(11):1505-1514.
35. Peters S., Schmidt W., Beerhues L. Regioselective oxidative phenol coupling of 2,3'4,6-tetrahydroxybenzophenone in cell cultures of Centaurium erythraea RAFN and Hypericum androsaemum L. Planta 1998, 204(1):64-69.
36. Beerhues L., Liu B. Biosynthesis of biphenyls and benzophenones-evolution of benzoic acid specific type III polyketide synthases in plants. Phytochemistry 2009, 70(15-16):1719-1727.
37. Schmidt W., Beerhues L. Alternative pathway of xanthone biosynthesis in cell cultures of Hypericum androsaemum L. FEBS Lett 1997, 420(2-3):143-146.
38. Nualkaew N., Morita H., Shimokawa Y., Kinjo K., Kushiro T., De-Eknamkul W., et al. Benzophenone synthase from Garcinia mangostana L. Pericarps. Phytochemistry 2012, 77:60-69.
39. Abd El-Mawla A.M., Schmidt W., Beerhues L. Cinnamic acid is a precursor of benzoic acids in cell cultures of Hypericum androsaemum but not in cell cultures of Centaurium erythraea L. Planta 2001, 212(2):288-293.
40. Wang C.-Z., Maier U.H., Keil M., Zenk M.H., Bacher A., Rohdich F., et al. Phenylalanine independent biosynthesis of 1,3,5,8-tetrahydroxyxanthone. A retrobiosynthetic NMR study with root cultures of Swertia chirata. Eur J Biochem 2003, 270(14):2950-2958.
41. Abd El-Mawla A.M., Beerhues L. Benzoic acid biosynthesis in cell cultures of Hypericum androsaemum. Planta 2002, 214(5):727-733.
42. Velisek J., Davidek J., Cejpek K. Biosynthesis of food constituents: natural pigments. Czech J Food Sci 2008, 26(2):73-98.
43. Jamwal A. Systematic review on xanthones and others isolates from genus Swertia. Int J Chem Pharm Sci 2012, 1(3):1115-1133.
44. Abe I., Utsumi Y., Oguro S., Noguchi H. The first plant type III polyketide synthase that catalyses formation of aromatic heptaketide. FEBS Lett 2004, 562(1-3):171-176.
45. Chen Z.-G., Fuji I., Ebizuka Y., Sankawa U. Purification and characterization of emodinanthrone oxygenase from Aspergillus terreus. Phytochemistry 1995, 38(2):299-305.
46. Shiono Y., Shiono N., Seo S., Oka S., Yamazaki Y.Z. Effects of polyphenolic anthrone derivatives, resistomycin and hypercin on apoptosis in human megakaryoblastic leukemia CMK-7 cell line. Z Naturforsch C, J Biosci 2002, 57(9-10):923-929.
47. Saleem R., Faizi S., Deeba F.R., Siddiqui B.S., Qazi M.H. Anthrones from Aloe barbadensis. Phytochemistry 1997, 45(6):1279-1282.
48. Lu T.S., Yi Y.H., Zhang Z.G., Zhang Z.Q., Hua N. A new 10-hydroxyl anthrone glycoside from Cassia siamea Lam. Chin. Chem Lett 2002, 13(8):731-733.
49. Peres V., Nagem T.J. Naturally occurring pentaoxygenated, hexaoxygenated and dimeric xanthones: a literature survey. Quim Nova 1997, 20(4):388-397.
50. Wolfender J.L., Hostettmann K. Liquid chromatography-UV detection and liquid chromatography-thermospray mass spectrometric analysis of Chironia (Gentianaceae). J Chromatogr 1993, 647:191-202.
51. Marston A., Hostettmann K. Modern separation methods. Nat Prod Rep 1991, 8:391-413.
52. Arends P., Helboe P. Applications of nuclear magnetic resonance spectroscopy in organic chemistry. Acta Chem Scand 1972, 26:4180.
53. Arends P., Helboe P., Moller J. Mass spectrometry of 667 priority pollutants. Org Mass Spectrom 1973, 7:667.
54. Sultanbawa M.U.S. Xanthonoids of tropical plants. Tetrahedron 1980, 36(1):1465-1506.
55. Rezanka T., Dembitsky V.M. Identification of acylated xanthone glycosides by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry in positive and negative modes from the lichen Umbilicaria proboscidea. J Chromatogr A 2003, 995:109-118.
56. Peres V., Nagem T.J., De Oliveira F.F. Tetraoxygenated naturally occurring xanthones. Phytochemistry 2000, 55:683-710.
57. Harborne J.B. Phytochemical methods 1973, Chapman and Hall, London, p. 278.
58. Mesquita A.A.L., Correa D.B., Gottlieb O.R., Magalhães M.T. Methods for the structural investigation of xanthones: Part II. Location of hydroxyl groups by ultraviolet and visible spectroscopy. Anal Chim Acta 1968, 42:311.
59. Huan Z., Qing-Wen Z., Lei W., Xiao-Qi Z., Wen-Cai Y., Yi-Tao W. Two new anthraquinone malonylglucosides from Polygonum cuspidatum. Nat Prod Res 2012, 26(14):1323-1327.
60. Chawla H.M., Chibber S.S., Seshadri T.R. Effect of chelation on the infrared carbonyl frequency of hydroxy-xanthones, benzophenones and anthraquinones. Proc lndian Acad Sci 1973, 78:141-148.
61. Schainmann F. Studies in the xanthone series-V: infra-red spectra of some substituted and extended xanthones. Tetrahedron 1962, 18(7):853-858.
62. Roberts J.C. Naturally occurring xanthones. Chem Rev 1961, 61(6):591-605.
63. Santesson J. Chemical and botanical guide to lichen products. Acta Chem Scand 1968, 22:2393.
64. Santesson J. Chroman and related compounds. Arkiv Kemi 1969, 30:479.
65. Barnes C.S., Occolowitz J.L. The mass spectra of some naturally occurring oxygen heterocycles and related compounds. Aust J Chem 1964, 17:975.
66. Mathis C.T., Goldstein J.H. Proton magnetic resonance spectra of 4-pyrone, chromone and xanthone. Spectrochimica Acta 1964, 20:871.
67. Barraclough D., Locksley H.D., Scheinmann F., Magalhães M.T., Gottlieb O.R. Applications of proton magnetic resonance spectroscopy in structural investigation of xanthones. J Chem Soc B 1970, 603.
68. Westerman P.W., Gunasekera S.P., Sultanhawa M.U.S., Kazlauskas R. Carbon-13 nuclear magnetic resonance spectra of some methyl and phenyl substituted 2H-azirines. Org Magn Reson 1977, 9:631.
69. 13C NMR spectroscopy of xanthones. Phytochemistry 1977, 16(6):735-740.
70. 13C-NMR spectroscopy of substituted xanthones. Tetrahedron 1979, 35:2035-2038.
71. Cai X.H., Luo X.D., Zhou J., Hao X.J. Quinones from Chirita eburnean. J Nat Prod 2005, 68:797-799.
72. Pinto M.M., Sousa M.E., Nascimento M.S. Xanthone derivatives: new insights in biological activities. Curr Med Chem 2005, 12(21):2517-2538.
73. Peres V., Nagem T.J. Naturally occurring pentaoxygenated, hexaoxygenated and dimeric xanthones: a literature survey. Quim Nova 1997, 20(4):388-397.
74. Ngoupayo J., Tabopda T.K., Ali M.S. Antimicrobial and immunomodulatory properties of prenylated xanthones from twigs of Garcinia staudtii. Bioorg Med Chem 2009, 17(15):5688-5695.
75. Rakuambo N.C., Meyer J.J., Hussein A. Xanthone isolated from Securidaca longependunculata with activity against erectile dysfunction. Fitoterapia 2004, 75(5):497-499.
76. Shen J., Tian Z., Yang J.S. The constituents from the stems of Garcinia cowa Roxb. and their cytotoxic activities. Pharmazie 2007, 62(7):549-551.
77. Louh G.N., Lannang A.M., Mbazoa C.D., Tangmouo J.G., Komguem J., Castilho P., et al. Polyanxanthone A, B and C, three xanthones from the wood trunk of Garcinia polyantha Oliv. Phytochemistry 2008, 69(4):1013-1017.
78. Lannang A.M., Louh G.N., Biloa B.M., Komguem J., Mbazoa C.D., Sondengam B.L., et al. Cytotoxicity of natural compounds isolated from the seeds of Garcinia afzelii. Planta Med 2010, 76(7):708-712.
79. Komguem J., Meli A.L., Manfouo R.N., Lontsi D., Ngounou F.N., Kuete V., et al. Xanthones from Garcinia smeathmannii (Oliver) and their antimicrobial activity. Phytochemistry 2005, 66(14):1713-1717.
80. Verbanac D., Jain S.C., Jain N., Chand M., Cipčić Paljetak H., Matijašić M., et al. An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization. Bioorg Med Chem 2012, 20(10):3180-3185.
81. Gnerre C., Thull U., Gaillard P., Carrupt P.A., Testa B., Fernandes E., et al. Natural and synthetic xanthones as monoamine oxidase inhibitors: biological assay and 3D-QSAR. Helv Chim Acta 2001, 84(3):552-570.
82. Gontijo S.V., De Souza T.C., Rosa A.I., Soares M.G., Viegas C., Dos Santos M.H., et al. Isolation and evaluation of the antioxidant activity of phenolic constituents of the Garcinia brasiliensis epicarp. Food Chem 2012, 132(3):1230-1235.
83. Hu L., Hu H., Wu W., Chai X., Luo J., Wu Q. Discovery of novel xanthone derivatives as xanthine oxidase inhibitors. Bioorg Med Chem Lett 2011, 21(13):4013-4015.
84. Zelefack F., Guilet D., Fabre N., Bayet C., Chevalley S., Ngouela S., et al. Cytotoxic and antiplasmodial xanthones from Pentadesma butyracea. J Nat Prod 2009, 72(5):954-957.
85. Mutanyatta J., Matapa B.G., Shushu D.D., Abegaz B.M. Homoisoflavonoids and xanthones from the tubers of wild and in vitro regenerated Ledebouria graminifolia and cytotoxic activities of some of the homoisoflavonoids. Phytochemistry 2003, 62(5):797-804.
86. Wang R.R., Gao Y.D., Ma C.H., Zhang X.J., Huang C.G., Huang J.F., et al. Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains. Molecules 2011, 16(5):4264-4277.
87. Ebada S.S., Schulz B., Wray V., Totzke F., Kubbutat M.H., Müller W.E., et al. Arthrinins A-D: novel diterpenoids and further constituents from the sponge derived fungus Arthrinium sp. Bioorg Med Chem 2011, 19(15):4644-4651.
88. Tamokou J.D.D., Tala M.F., Wabo H.K., Kuiate J.R., Tane P. Antimicrobial activities of methanol extract and compounds from stem bark of Vismia rubescens. J Ethnopharmacol 2009, 124(3):571-575.
89. El-Shanawany M.A., Mohamed G.A., Nafady A.M., Ibrahim S.R.M., Radwan M.M., Ross S.A. A new xanthone from the roots of Centaurium spicatum. Phytochem Lett 2011, 4(2):126-128.
90. Chen J.J., Peng C.F., Huang H.Y., Chen I.S. Benzopyrans, biphenyls and xanthones from the root of Garcinia linii and their activity against Mycobacterium tuberculosis. Planta Med 2006, 72(5):473-477.
91. Tanaka N., Kashiwada Y., Kim S.Y., Sekiya M., Ikeshiro Y., Takaishi Y. Xanthones from Hypericum chinense and their cytotoxicity evaluation. Phytochemistry 2009, 70(11-12):1456-1461.
92. Yimdjo M.C., Azebaze A.G., Nkengfack A.E., Meyer A.M., Bodo B., Fomum Z.T. Antimicrobial and cytotoxic agents from Calophyllum inophyllum. Phytochemistry 2004, 65(20):2789-2795.
93. Ding L., Liu B., Zhang S.D., Hou Q., Qi L.L., Zhou Q.Y. Cytotoxicity, apoptosis-inducing effects and structure-activity relationships of four natural xanthones from Gentianopsis paludosa Ma in HepG2 and HL-60 cells. Nat Prod Res 2011, 25(7):669-683.
94. Wabo H.K., Kikuchi H., Katou Y., Tane P., Oshima Y. Xanthones and a benzophenone from the roots of Pentadesma butyracea and their antiproliferative activity. Phytochem Lett 2010, 3:104-107.
95. Kuete V., Alibert-Franco S., Eyong K.O., Ngameni B., Folefoc G.N., Nguemeving J.R., et al. Antibacterial activity of some natural products against bacteria expressing. Int J Antimicrob Agents 2011, 37(2):156-161.
96. Isaias D.E., Niero R., Noldin V.F., de Campos-Buzzi F., Yunes R.A., Delle-Monache F., et al. Pharmacological and phytochemical investigations of different parts of Calophyllum brasiliense (Clusiaceae). Pharmazie 2004, 59(11):879-881.
97. Chen J.J., Chen I.S., Duh C.Y. Cytotoxic xanthones and biphenyls from the root of Garcinia linii. Planta Med 2004, 70(12):1195-1200.
98. Wang Q.X., Bao L., Yang X.L., Guo H., Yang R.N., Ren B., et al. Polyketides with antimicrobial activity from the solid culture of an endolichenic fungus Ulocladium sp. Fitoterapia 2012, 83(1):209-214.
99. Sob S.V.T., Wabo H.K., Tchinda A.T., Tane P., Ngadjui B.T., Ye Y. Anthraquinones, sterols, triterpenoids and xanthones from Cassia obtusifolia. Biochem Syst Ecol 2010, 38(3):342-345.
100. Fujimoto H., Satoh Y., Yamaguchi K., Yamazaki M. Monoamine oxidase inhibitory constituents from Anixiella micropertusa. Chem Pharm Bull 1998, 46(10):1506-1510.
101. Fouotsa H., Mbazoa C.D., Kengfack A.E., Rasheed S., Marasini B.P., Ali Z., et al. Xanthones inhibitors of α-glucosidase and glycation from Garcinia nobilis. Phytochem Lett 2012, 5(2):236-239.
102. Nguemeving J.R., Azebaze A.G., Kuete V., Eric Carly N.N., Beng V.P., Meyer M., et al. Laurentixanthones A and B, antimicrobial xanthones from Vismia laurentii. Phytochemistry 2006, 67(13):1341-1346.
103. Kouam S.F., Njonkou Y.L.N., Kuigoua G.M., Ngadjui B.T., Hussain H., Green I.R., et al. Psorantin, a unique methylene linked dimer of vismin and kenganthranol E, two anthranoid derivatives from the fruits of Psorospermum aurantiacum (Hypericaceae). Phytochem Lett 2010, 3(4):185-189.
104. Leet J.E., Liu X., Drexler D.M., Cantone J.L., Huang S., Mamber S.W., et al. Cytotoxic xanthones from Psorospermum molluscum from the Madagascar rain forest. J Nat Prod 2008, 71(3):460-463.
105. Pinto E., Afonso C., Duarte S., Vale-Silva L., Costa E., Sousa E., et al. Antifungal activity of xanthones: evaluation of their effect on ergosterol biosynthesis by high-performance liquid chromatography. Chem Biol Drug Des 2011, 77(3):212-222.
106. Shiu W.K., Gibbons S. Anti-staphylococcal acylphloroglucinols from Hypericum beanii. Phytochemistry 2006, 67(23):2568-2572.
107. Dao T.T., Dang T.T., Nguyen P.H., Kim E., Thuong P.T., Oh W.K. Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses. Bioorg Med Chem Lett 2012, 22(11):3688-3692.
108. Ryu H.W., Curtis-Long M.J., Jung S., Jin Y.M., Cho J.K., Ryu Y.B., et al. Xanthones with neuraminidase inhibitory activity from the seedcases of Garcinia mangostana. Bioorg Med Chem 2010, 18(17):6258-6564.
109. Meli Lannang A., Lontsi D., Ngounou F.N., Sondengam B.L., Nkengfack A.E., van Heerden F.R., et al. Securidacaxanthone A, a heptaoxygenated xanthone from Securidaca longepedunculata. Fitoterapia 2006, 77(3):199-202.
110. Ferchichi L., Derbré S., Mahmood K., Touré K., Guilet D., Litaudon M., et al. Bioguided fractionation and isolation of natural inhibitors of advanced glycation end-products (AGEs) from Calophyllum flavoramulum. Phytochemistry 2012, 78:98-106.
111. Iinuma M., Tosa H., Tanaka T., Asai F., Kobayashi Y., Shimano R., et al. Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylococcus aureus. J Pharm Pharmacol 1996, 48(8):861-865.
112. Okorie D.A. A new phthalide and xanthones from Anthocleista djalonensis and Anthocleista vogelli. Phytochemistry 1976, 15(11):1799-1800.
113. Hussein A.A., Bozzi B., Correa M., Capson T.L., Kursar T.A., Coley P.D., et al. Bioactive constituents from three Vismia species. J Nat Prod 2003, 66(6):858-860.
114. Suksamrarn S., Komutiban O., Ratananukul P., Chimnoi N., Lartpornmatulee N., Suksamrarn A. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem Pharm Bull (Tokyo) 2006, 54(3):301-305.
115. Ngouela S., Lenta B.N., Noungoue D.T., Ngoupayo J., Boyom F.F., Tsamo E., et al. Anti-plasmodial and antioxidant activities of constituents of the seed shells of Symphonia globulifera Linn. f. Phytochemistry 2006, 67(3):302-306.
116. Shahat A.A., Hassan R.A., Nazif N.M., Van Miert S., Pieters L., Hammuda F.M., et al. Isolation of mangiferin from Bombax malabaricum and structure revision of shamimin. Planta Med 2003, 69(11):1068-1070.
117. Joubert E, Botha M, Maicu C, De Beer D, Manley M. Rapid screening methods for estimation of mangiferin and xanthone contents of Cyclopia subternata plant material. S Afr J Bot <>. http://dx.doi.org/10.1016/j.sajb.2012.07.019.
118. Dar A., Faizi S., Naqvi S., Roome T., Zikr-ur-Rehman S., Ali M., et al. Analgesic and antioxidant activity of mangiferin and its derivatives: the structure-activity relationship. Biol Pharm Bull 2005, 28(4):596-600.
119. Barreto J.C., Trevisan M.T., Hull W.E., Erben G., de Brito E.S., Pfundstein B., et al. Characterization and quantitation of polyphenolic compounds in bark, kernel, leaves, and peel of mango (Mangifera indica L.). J Agric Food Chem 2008, 56(14):5599-5610.
120. Leiro J.M., Alvarez E., Arranz J.A., Siso I.G., Orallo F. In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochem Pharmacol 2003, 65(8):1361-1371.
121. Azebaze A.G., Meyer M., Bodo B., Nkengfack A.E. Allanxanthone B, a polyisoprenylated xanthone from the stem bark of Allanblackia monticola Staner L.C. Phytochemistry 2004, 65(18):2561-2564.
122. Abe F., Nagafuji S., Okabe H., Akahane H., Estrada-Muñiz E., Huerta-Reyes M., et al. Trypanocidal constituents in plants 3. Leaves of Garcinia intermedia and heartwood of Calophyllum brasiliense. Biol Pharm Bull 2004, 27(1):141-143.
123. Queiroz E.F., Ahua K.M., Hostettmann K. Investigation of medicinal plants for the treatment of neglected diseases. Chimia 2005, 59(6):299-302.
124. Pana E., Cao S., Brodie P.J., Miller J.S., Rakotodrajaona R., Ratovoson F., et al. An antiproliferative xanthone of Symphonia pauciflora from the Madagascar rainforest. Nat Prod Commun 2010, 5(5):751-754.
125. Lenta B.N., Vonthron-Sénécheau C., Weniger B., Devkota K.P., Ngoupayo J., Kaiser M., et al. Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds from Allanblackia monticola and Symphonia globulifera. Molecules 2007, 12(8):1548-1557.
126. Lannang A.M., Komguem J., Ngninzeko F.N., Tangmouo J.G., Lontsi D., Ajaz A., et al. Antioxidant benzophenone and xanthones from the root bark of Garcinia smeathmannii. Bull Chem Soc Ethiop 2006, 20(2):247-252.
127. Magadula J.J. A bioactive isoprenylated xanthone and other constituents of Garcinia edulis. Fitoterapia 2010, 81(5):420-423.
128. Nkengfack A.E., Mkounga P., Fomum Z.T., Meyer M., Bodo B. Globulixanthones A and B, two new cytotoxic xanthones with isoprenoid groups from the root bark of Symphonia globulifera. J Nat Prod 2002, 65(5):734-736.
129. Nkengfack A.E., Mkounga P., Meyer M., Fomum Z.T., Bodo B. Globulixanthones C, D and E: three prenylated xanthones with antimicrobial properties from the root bark of Symphonia globulifera. Phytochemistry 2002, 61(2):181-187.
130. Botta B., Delle Monache G., Delle Monache F., Marini Bettolo G.B., Menichini F. Vismione H. and prenylated xanthones from Vismia guineensis. Phytochemistry 1986, 25(5):1217-1219.
131. Kuete V. Potential of Cameroonian plants and derived-products against microbial infections: a review. Planta Med 2010, 76:1479-1491.
132. Kuete V., Efferth T. Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol 2010, 1:123.
133. Larcher G., Morel C., Tronchin G., Landreau A., Séraphin D., Richomme P., et al. Investigation of the antifungal activity of caledonixanthone E and other xanthones against Aspergillus fumigatus. Planta Med 2004, 70(6):569-571.
134. Hay A.E., Hélesbeux J.J., Duval O., Labaïed M., Grellier P., Richomme P. Antimalarial xanthones from Calophyllum caledonicum and Garcinia vieillardii. Life Sci 2004, 75(25):3077-3085.
135. Tene M., Tane P., Kuiate J.R., Tamokou Jde D., Connolly J.D. Anthocleistenolide, a new rearranged nor-secoiridoid derivative from the stem back of Anthocleista vogelii. Planta Med 2008, 74(1):80-83.
136. Kang W.Y., Xu X.J. Structure of a new xanthone from Securidaca inappendiculata. Chem Nat Compd 2008, 44(4):432-434.
137. Anantachoke N., Tuchinda P., Kuhakarn C., Pohmakotr M., Reutrakul V. Prenylated caged xanthones: chemistry and biology. Pharm Biol 2012, 50(1):78-91.
138. Boik J. Natural compounds in cancer therapy 2001, Oregon Medical Press, MN.
139. Brahemi G., Kona F.R., Fiasella A., Buac D., Soukupov J., Brancale A., et al. Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer. J Med Chem 2010, 53:2757-2765.
140. Pedro M., Cerqueira F., Sousa M.E., Nascimento M.S., Pinto M. Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorg Med Chem 2002, 10(12):3725-3730.
141. Jiang D.J., Hu G.Y., Jiang J.L., Xiang H.L., Deng H.W., Li Y.J. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Bioorg Med Chem 2003, 11(23):5171-5177.
142. Kuete V., Wabo H.K., Eyong K.O., Feussi M.T., Wiench B., Krusche B., et al. Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants. PLoS One 2011, 6(8):e21762.
143. Zou Y.S., Hou A.J., Zhu G.F., Chen Y.F., Sun H.D., Zhao Q.S. Cytotoxic isoprenylated xanthones from Cudrania tricuspidata. Bioorg Med Chem 2004, 12(8):1947-1953.
144. Liu Y., Ke Z., Cui J., Chen W.H., Ma L., Wang B. Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors. Bioorg Med Chem 2008, 16(15):7185-7192. [a multidrug-resistant phenotype. Int J Antimicrob Agents 2011; 37(2): 156-61].
145. Cholinesterase-blood-overview, <> [accessed 09.09.13]. http://www.umm.edu/ency/article/003358.htm.
146. Cholinesterase, <> [accessed 09.09.12]. http://en.wikipedia.org/wiki/Cholinesterase.
147. Tipton K.F., Boyce S., O'Sullivan J., Davey G.P., Healy J. Monoamine oxidases: certainties and uncertainties. Curr Med Chem. 2004, 11(15):1965-1982.
148. Monoamine oxidase, <> [accessed 10.09.12]. http://en.wikipedia.org/wiki/Monoamine_oxidase.
149. Meyer J.H., Ginovart N., Boovariwala A., Sagrati S., Hussey D., Garcia A., et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006, 63(11):1209-1216.
150. Domino E.F., Khanna S.S. Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients. Am J Psychiatry 1976, 133(3):323-326.
151. Schildkraut J.J., Herzog J.M., Orsulak P.J., Edelman S.E., Shein H.M., Frazier S.H. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Am J Psychiatry 1976, 133(4):438-440.
152. Riederer P., Lachenmayer L., Laux G. Clinical applications of MAO-inhibitors. Curr Med Chem 2004, 11(15):2033-2043.
153. Ardan T., Kovaceva J., Cejková J. Comparative histochemical and immunohistochemical study on xanthine oxidoreductase/xanthine oxidase in mammalian corneal epithelium. Acta Histochem 2004, 106(1):69-75.
154. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radic Biol Med 2002, 33(6):774-797.
155. Dawson J., Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?. Br J Clin Pharmacol 2006, 62(6):633-644.
156. Protein kinase, <> [accessed 12.09.12]. http://en.wikipedia.org/wiki/Protein_kinase.
157. Ryu Y.B., Curtis-Long M.J., Lee J.W., Ryu H.W., Kim J.Y., Lee W.S., et al. Structural characteristics of flavanones and flavones from Cudrania tricuspidata for neuraminidase inhibition. Bioorg Med Chem Lett 2009, 19(17):4912-4915.
158. Jantan I., Saputri F.C. Benzophenones and xanthones from Garcinia cantleyana var. cantleyana and their inhibitory activities on human low-density lipoprotein oxidation and platelet aggregation. Phytochemistry 2012, 80:58-63.
159. Boonnak N., Karalai C., Chantrapromma S., Ponglimanont C., Kanjana-Opas A., Chantrapromma K., et al. Quinonoids from the barks of Cratoxylum formosum subsp. pruniflorum. Canadian J Chem 2007, 85(5):341-345.
160. Elix J.A., Gaul K.L., Lumbsch H.T. Isolation of a novel lichen xanthone from the genus Diploschistes. Aust J Chem 1987, 40:1031-1033.
161. Reutrakul V., Chanakul W., Pohmakotr M., Jaipetch T., Yoosook C., Kasisit J., et al. Anti-HIV-1 constituents from leaves and twigs of Cratoxylum arborescens. Planta Med 2006, 72(15):1433-1435.